Literature DB >> 23990812

Fermented milk containing Lactobacillus GG alleviated DSS-induced colitis in mice and activated epidermal growth factor receptor and Akt signaling in intestinal epithelial cells.

Kazutoyo Yoda1, Fang He, Kenji Miyazawa, Masaru Hiramatsu, Fang Yan.   

Abstract

Lactobacillus rhamnosus GG was assessed for its ability to alleviate DSS-induced colitis in mice and activate epidermal growth factor receptor and Akt signaling in intestinal epithelial cells. In this study mice were treated with DSS to induce colitis and they were given Lactobacillus GG fermented milk to assess the effect of probiotic on colitis. Lactobacillus GG fermented milk significantly reduced the colitis associated changes suggesting a protective effect against DSS induced colitis.

Entities:  

Keywords:  EGF receptor; Lactobacillus GG; colitis; fermented milk; intestinal epithelial cell

Year:  2012        PMID: 23990812      PMCID: PMC3744661          DOI: 10.3402/mehd.v23i0.18586

Source DB:  PubMed          Journal:  Microb Ecol Health Dis        ISSN: 0891-060X


  2 in total

1.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; Robert Whitehead; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

Review 2.  Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases.

Authors:  Fang Yan; D Brent Polk
Journal:  Gut Microbes       Date:  2012-01-01
  2 in total
  2 in total

Review 1.  Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events.

Authors:  Amy Llewellyn; Andrew Foey
Journal:  Nutrients       Date:  2017-10-23       Impact factor: 5.717

2.  A Microbial Feed Additive Abates Intestinal Inflammation in Atlantic Salmon.

Authors:  Ghana Vasanth; Viswanath Kiron; Amod Kulkarni; Dalia Dahle; Jep Lokesh; Yoichiro Kitani
Journal:  Front Immunol       Date:  2015-08-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.